Growth Hormone Receptor Upregulation The peptide increases the expression of growth hormone receptors on cell surfaces
Vascular Signalling: Preclinical studies have examined AHK-Cu in relation to vascular endothelial growth factor (VEGF) expression and angiogenic pathways
In the central human study by Teichman and colleagues, a single subcutaneous dose produced a dose-dependent GH rise of 2- to 10-fold that persisted for at least 6 days, plus an IGF-1 rise of 1.5- to 3-fold over 9 to 11 days (Teichman et al., 2006)
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Narula N., Wong E.C.L., Dehghan M., Mente A., Rangarajan S., Lanas F., Lopez-Jaramillo P., Rohatgi P., Lakshmi P.V.M., Varma R.P., et al